B16 Melanoma Cells ExposedIn Vitroto Long-Term IFN-α Treatment (B16α Cells) as Activators of Tumor Immunity in Mice
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
Selection of Successive Tumour Lines for Metastasis
1973 • 1,360 citations
Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin.
1953 • 686 citations
A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin
1976 • 478 citations
Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity.
1989 • 284 citations
Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution.
1977 • 169 citations
Tumour‐specific immunity against spontneous rat tumours
1966 • 104 citations
Cytokine-induced enhancement of ICAM-1 expression results in increased vulnerability of tumor cells to monocyte-mediated lysis.
1991 • 103 citations
Treatment of a human breast cancer xenograft with an adenovirus vector containing an interferon gene results in rapid regression due to viral oncolysis and gene therapy.
1996 • 89 citations
Retrovirus antigens recognized by cytolytic T lymphocytes activate tumor rejection in vivo
1987 • 85 citations
FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens.
1989 • 75 citations
Biochemical correlates of phenotypic reversion in interferon-treated mouse cells transformed by a human oncogene
1984 • 71 citations
Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
1993 • 65 citations
Effect of Prolonged Interferon Treatment on Mouse Embryonic Fibroblasts Transformed by Murine Sarcoma Virus
1970 • 58 citations
IFN‐α1 gene transfection completely abolishes the tumorigenicity of murine B16 melanoma cells in allogeneic DBA/2 mice and decreases their tumorigenicity in syngeneic C57BL/6 mice
1995 • 41 citations
Naturally Arising Tumors of the Inbred WAB/Not Rat Strain. II. Immunogenicily of Transplanted Tumors<xref ref-type="fn" rid="fn2">2</xref><xref ref-type="fn" rid="fn3">3</xref>
1981 • 41 citations
Interferons in the Therapy of Solid Tumors
1994 • 39 citations
Association of phenotypic reversion of transformed cells induced by interferon with morphological and biochemical changes in the cytoskeleton.
1981 • 39 citations
Gene therapy with an adeno-associated virus carrying an interferon gene results in tumor growth suppression and regression.
1996 • 32 citations
Enhancement of Surface Antigen Expression on Human Breast Carcinoma Cells by Recombinant Human Interferons
1988 • 30 citations
Interferon-mediated enhancement of metastasis. Are MHC antigens involved?
1987 • 29 citations
EnhancedIn VivoSensitivity ofIn VitroInterferon-Treated B16 Melanoma Cells to CD8 Cells and Activated Macrophages
1996 • 25 citations
Interferons for the Treatment of Hematological Malignancies
1994 • 22 citations
INJECTION OF IRRADIATED B16 MELANOMA GENETICALLY-MODIFIED TO SECRETE IFN-ALPHA CAUSES REGRESSION OF AN ESTABLISHED TUMOR
1995 • 22 citations
Enhanced in vivo sensitivity to interferon with in vitro resistant B16 tumor cells in mice
1994 • 16 citations
Detection and Characterization of Murine Ecotropic Recombinant Virus in Myeloma and Hybridoma Cells
1994 • 16 citations
Effects of Interferons and Cytokines on Melanoma Cells.
1993 • 6 citations
Modulation of tumour associated antigen expressed on human squamous cell carcinoma cell lines by recombinant interferon-α
1993 • 3 citations